StonvexLoading…
StonvexCore line items from CBRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $39.90B | $35.18B | $31.50B | $30.17B |
Operating Income | $1.75B | $1.41B | $1.12B | $1.51B |
Net Income | $1.16B | $968.00M | $986.00M | $1.41B |
EPS (Diluted) | $3.85 | $3.14 | $3.15 | $4.29 |
Total Assets | $30.88B | $24.38B | $22.55B | $20.51B |
Total Liabilities | $21.25B | $15.19B | $13.48B | $11.91B |
Cash & Equivalents | $1.86B | $1.11B | $1.26B | $1.32B |
Free Cash Flow OCF − CapEx | $1.19B | $1.40B | $175.00M | $1.37B |
Shares Outstanding | 295.73M | 302.05M | 304.89M | 311.01M |